Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2019/4874921 http://scihub22266oqcxt.onion/10.1155/2019/4874921 31192005!6525869!31192005     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cardiol+Res+Pract 2019 ; 2019 (ä): 4874921 Nephropedia Template TP {{tp|p=31192005|t=2019. Prevention of Cardiovascular Disease: Screening for Magnesium Deficiency |pdf=|usr=}}{{31192005}} gab.com Text Prevention of Cardiovascular Disease: Screening for Magnesium Deficiency JO: Cardiol Res Pract http://www.kidney.de/pget.php?&tw=1&pmid=31192005 #FOAvip Magnesium is an essential mineral naturally present in the human body, where it acts as cofactor in several enzymatic reactions. Magnesium is a key cardiovascular regulator, which maintains electrical, metabolic, and vascular homeostasis. Moreover, magnesium participates in inflammation and oxidative processes. In fact, magnesium deficiency is involved in the pathophysiology of arterial hypertension, diabetes mellitus, dyslipidemia, metabolic syndrome, endothelial dysfunction, coronary artery disease, cardiac arrhythmias, and sudden cardiac death. In consideration of the great public-health impact of cardiovascular disease, the recognition of the negative effects of magnesium deficiency suggests the possible role of hypomagnesaemia as cardiovascular risk factor and the use of serum magnesium level for the screening and prevention of cardiovascular risk factors and cardiovascular diseases. Moreover, it might help with the identification of new therapeutical strategies for the management of cardiovascular disease through magnesium supplementation. Twit Text FOAVip Prevention of Cardiovascular Disease: Screening for Magnesium Deficiency ????Cardiol Res Pract http://www.kidney.de/pget.php?&tw=1&pmid=31192005 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=31192005 #FOAvip English Wikipedia <ref>{{Cite pmid|31192005}}</ref> Prevention of Cardiovascular Disease: Screening for Magnesium Deficiency #MMPMID31192005 Severino P; Netti L; Mariani MV; Maraone A; D'Amato A; Scarpati R; Infusino F; Pucci M; Lavalle C; Maestrini V; Mancone M; Fedele F Cardiol Res Pract 2019[]; 2019 (ä): 4874921 PMID31192005show ga Magnesium is an essential mineral naturally present in the human body, where it acts as cofactor in several enzymatic reactions. Magnesium is a key cardiovascular regulator, which maintains electrical, metabolic, and vascular homeostasis. Moreover, magnesium participates in inflammation and oxidative processes. In fact, magnesium deficiency is involved in the pathophysiology of arterial hypertension, diabetes mellitus, dyslipidemia, metabolic syndrome, endothelial dysfunction, coronary artery disease, cardiac arrhythmias, and sudden cardiac death. In consideration of the great public-health impact of cardiovascular disease, the recognition of the negative effects of magnesium deficiency suggests the possible role of hypomagnesaemia as cardiovascular risk factor and the use of serum magnesium level for the screening and prevention of cardiovascular risk factors and cardiovascular diseases. Moreover, it might help with the identification of new therapeutical strategies for the management of cardiovascular disease through magnesium supplementation. äPrevention of Cardiovascular Disease: Screening for Magnesium Deficien(epmc).pdf DeepDyve Pubget Overpricing